Assignee
MERZ & CO GMBH & CO
DE·25 granted patents·1,318 citations·filing 1983–2000
Top patents by PatentIndex Score
25 records- 0196US6034134A1-Amino-alkylcyclohexane NMDA receptor antagonistsMERZ & CO GMBH & CO·Filed 1998·Granted Mar 7, 2000·238 cites·22 claims
- 0292US5061703AAdamantane derivatives in the prevention and treatment of cerebral ischemiaMERZ & CO GMBH & CO·Filed 1990·Granted Oct 29, 1991·196 cites·13 claims
- 0391US4808388AFoamable creamsMERZ & CO GMBH & CO·Filed 1987·Granted Feb 28, 1989·181 cites·7 claims
- 0488US5382601AMemantine-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereofMERZ & CO GMBH & CO·Filed 1993·Granted Jan 17, 1995·119 cites·22 claims
- 0587US5498420AStable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositionsMERZ & CO GMBH & CO·Filed 1995·Granted Mar 12, 1996·202 cites·18 claims
- 0684US6197338B1Effervescent bath tablet, method of preparing it, and the use thereofMERZ & CO GMBH & CO·Filed 2000·Granted Mar 6, 2001·24 cites·13 claims
- 0784US6071966A1-amino-alkylcyclohexane NMDA receptor antagonistsMERZ & CO GMBH & CO·Filed 1998·Granted Jun 6, 2000·74 cites·12 claims
- 0882US4602037AXanthates and antiviral use thereofMERZ & CO GMBH & CO·Filed 1983·Granted Jul 22, 1986·21 cites·60 claims
- 0980US4851435AAntiviral and antitumor xanthate pharmaceutical compositionsMERZ & CO GMBH & CO·Filed 1986·Granted Jul 25, 1989·30 cites·24 claims
- 1078US5288501AMechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredientsMERZ & CO GMBH & CO·Filed 1992·Granted Feb 22, 1994·64 cites·23 claims
- 1175US6255348B1Use of aminoadamantane compounds as immunoregulatorsMERZ & CO GMBH & CO·Filed 2000·Granted Jul 3, 2001·9 cites·2 claims
- 1267US5766628ABath and shower composition having vesicle-forming properties and method for the production and use thereofMERZ & CO GMBH & CO·Filed 1997·Granted Jun 16, 1998·37 cites·18 claims
- 1361US5776935APyrido-phtalazin diones and their use against neurological disorders associated with excitotoxicity and malfunctioning of glutamatergic neurotransmissionMERZ & CO GMBH & CO·Filed 1996·Granted Jul 7, 1998·22 cites·12 claims
- 1455US6172116B1Use of aminoadamantane compounds as immunoregulatorsMERZ & CO GMBH & CO·Filed 1996·Granted Jan 9, 2001·12 cites·10 claims
- 1554US5262162ACerebral-activating extractMERZ & CO GMBH & CO·Filed 1991·Granted Nov 16, 1993·17 cites·15 claims
- 1653US4758581APyridyl N-oxidesMERZ & CO GMBH & CO·Filed 1987·Granted Jul 19, 1988·6 cites·3 claims
- 1751US4789401ASoluble collagen spongeMERZ & CO GMBH & CO·Filed 1986·Granted Dec 6, 1988·34 cites·9 claims
- 1846US4939177AUse of avarol for the control of AIDS and ARCMERZ & CO GMBH & CO·Filed 1987·Granted Jul 3, 1990·3 cites·2 claims
- 1941US5988434ADosage withdrawal apparatusMERZ & CO GMBH & CO·Filed 1993·Granted Nov 23, 1999·14 cites·22 claims
- 2041US5254549ANew BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugsMERZ & CO GMBH & CO·Filed 1991·Granted Oct 19, 1993·8 cites·12 claims
- 2137US5026732AUse of avarone for the control of AIDS and ARCMERZ & CO GMBH & CO·Filed 1989·Granted Jun 25, 1991·1 cites·2 claims
- 2237US4939178AUse of avarol for the control of adult T-cell leukemia/lymphomaMERZ & CO GMBH & CO·Filed 1987·Granted Jul 3, 1990·5 cites·1 claims
- 2330US4981869AXanthates as antitumor agentsMERZ & CO GMBH & CO·Filed 1989·Granted Jan 1, 1991·1 cites·29 claims
- 2429US5001162AUse of avarone for the control of adult T-cell leukemia/lymphomaMERZ & CO GMBH & CO·Filed 1989·Granted Mar 19, 1991·0 cites·2 claims
- 2524US5180748AAvarone and its pharmaceutical compositions and use as an antiviral agentMERZ & CO GMBH & CO·Filed 1989·Granted Jan 19, 1993·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when MERZ & CO GMBH & CO files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →